Aurobindo Pharma standalone net profit rises 101.33% in the September 2020 quarter
Sales rise 40.71% to Rs 4425.43 crore
Net profit of Aurobindo Pharma rose 101.33% to Rs 801.54 crore in the quarter ended September 2020 as against Rs 398.13 crore during the previous quarter ended September 2019. Sales rose 40.71% to Rs 4425.43 crore in the quarter ended September 2020 as against Rs 3145.12 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales4425.433145.12 41 OPM %27.2820.07 -PBDT1249.34639.99 95 PBT1129.20522.06 116 NP801.54398.13 101Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 12 2020 | 8:25 AM IST